Q2 Earnings Update: Sundaram Finance, Nykaa, Lenskart, Biocon and More

Several key Indian companies released their financial results for the second quarter of fiscal year 2027 on November 4, reflecting a mixed performance across sectors. Leading firms including Sundaram Finance, Nykaa, Lenskart, and HUDCO posted notable profit growth, while others like Biocon and Zydus Lifesciences experienced declines in their quarterly earnings.

The broad market responded positively, with the BSE Sensex closing 383.55 points higher at 77,301.40 and the Nifty 50 gaining 149.75 points to finish at 23,960.60. Precious metals also saw gains, with gold prices rising by 3,276 units and silver by 6,995 units, while crude oil prices dropped by 144 points.

Highlights from Top Performers

FSN E-Commerce Ventures, the parent company of Nykaa, reported a 36% increase in standalone profit after tax (PAT), reaching ₹16.71 crore for Q2 FY27 compared to ₹12.25 crore for the same period last year. The board also approved an acquisition of an 82% stake in Simply Nam for up to ₹33 crore, indicating growth strategies beyond the existing portfolio.

Lenskart Solutions demonstrated an impressive 69.3% jump in standalone PAT, registering ₹167.85 crore during the quarter. This reflects the company’s continued expansion in the eyewear segment, buoyed by increasing consumer demand and digital penetration.

Sundaram Finance reported its standalone PAT at ₹475.07 crore, marking resilience in the financial services sector amid a complex economic backdrop. HUDCO also saw a 28.3% rise in standalone PAT, reaching ₹911.04 crore, signaling strength in the housing finance market.

Ramco Industries posted a standalone PAT of ₹58 crore, maintaining steady profitability despite challenging raw material costs. Biocon, however, reported a significant decrease in consolidated net profit, falling by 57.3% to ₹56.7 crore from ₹132.8 crore in the previous year’s quarter. This decline was attributed to increased expenses despite higher income, as the company advances its biosimilar portfolio.

Zydus Lifesciences faced a 62% year-on-year drop in Q2 profit, landing at ₹714.5 crore, highlighting pressures from pricing and competitive dynamics in the pharmaceutical sector.

Other Notable Results

Apollo Tyres increased its consolidated PAT by 13% to ₹292 crore, supported by a 16.64% rise in revenue to ₹7,968 crore. The profit figure includes a ₹26 crore pre-tax restructuring cost, recorded as an exceptional item.

1Point1 Solutions Limited showed strong growth with a 147% increase in consolidated revenue to ₹174.96 crore and an 87% rise in PAT to ₹18.41 crore, bolstered by a recent $10.8 million contract in Costa Rica.

State-run NLC India Ltd more than doubled its net profit to ₹1,380.67 crore, driven by higher revenues of ₹4,732.35 crore, compared to the previous year.

On the downside, FMCG company Jyothy Labs saw an 88% drop in net profit to ₹10.6 crore due to rising input costs and consumer affordability challenges.

Century Plyboards posted a 46% increase in consolidated net profit to ₹104 crore, with total income rising to ₹1,782 crore, reflecting growth in demand for plywood and allied products.

Market Impact and Sector Trends

The mixed earnings landscape underscores the varying pressures across industries as companies navigate inflation, supply chain constraints, and shifting consumer behavior. Financial services firms like Sundaram Finance and HUDCO have benefited from improved credit demand and cautious risk management, while pharmaceutical companies face margin pressures amid rising costs and competitive pricing.

The retail and e-commerce sectors continue to expand, as shown by Nykaa and Lenskart’s strong performances. These companies leverage digital platforms to tap into growing consumer bases and evolving shopping habits.

Investors reacted with enthusiasm to several positive earnings reports, lifting shares of SBI, Bajaj Finserv, Emcure Pharma, and Awfis Space. Conversely, stocks such as MCX and Bata India saw declines, reflecting sector-specific challenges.

Looking ahead, more companies including BSE, Cummins India, Apollo Hospitals, Aurobindo Pharma, NHPC, Dabur India, Torrent Power, Balkrishna Industries, Premier Energies, PI Industries, and Physicswallah are scheduled to announce their Q2 results, which will provide further clarity on the overall economic recovery and sectoral performance.

This earnings season highlights the importance of monitoring corporate profitability and market dynamics as India’s economy continues its post-pandemic recovery amid global uncertainties.